Avid Bioservices Inc (CDMO)

[asmarterwookie]

My bet there is some gravy but more earthly vs astronomical.

Eltoukhy projects the U.S. market potential for the liquid biopsy at more than $20 billion a year.

On Sunday, Illumina announced the formation of a new company, called GRAIL, which will focus on blood-based cancer screening. The company is majority owned by Illumina and funded by more than $100 million in Series A financing from Illumina and ARCH Venture Partners, with participating investments from Bezos Expeditions and Sutter Hill Ventures

.

https://www.cnbc.com/2016/01/11/a-revolutionary-blood-test-that-can-detect-cancer.html

Remember, GRAIL is the company who mentioned it's like find a needle in a haystack.

Peregrine may just have the proper magnet.....

Phosphatidyserine and Exosomes are inseparable..it seems....

If Peregrine does have the better exosome trap then what part of a possible $20 Billion market can it attract?

I can be happy with earthly....for exosomes alone...

Theransostics will further the therapeutic side IMHO.

INVEST IN THE TECHNOLOGY because MABufacturing is the icing(ADD for now). IMHO

ADD: After a quick GOOGLE. MABufacturing could be a nice cake as well...
Monoclonal Antibodies (mAbs) Market Size Worth $138.6 Billion By 2024
http://www.grandviewresearch.com/press-release/global-monoclonal-antibodies-market

Dear Mr. Stafford, Mr White and all valuators.

What value ya thinking?
One definitive statement and we can see a true Earthly value.....maybe even Earth Shaking........

wook